A Prospective Randomized, Multicenter Trial Evaluating the Efficacy and Safety of Combined Therapy with Pirfenidone and Inhaled N-Acetylcysteine for Idiopathic Pulmonary Fibrosis

Authors :: Yoshinori Tanino
Kazuhisa Takahashi
Yoshio Taguchi
Yasuhiro Kondoh
Hajime Takizawa
Fumikazu Sakai
T. Kishaba
T. Suda
T. Saito
Sakae Homma
Masashi Bando
Noboru Hattori
K. Kataoka
Sei Sasaki
K. Kishi
Susumu Sakamoto
Hiroshi Mukae
Naohiko Inase
Kazuyoshi Kuwano
Takeshi Johkoh
Yasuhiko Nishioka
Tomoaki Hoshino
T. Kido
Source :: B34. ILD CELLULAR MECHANISMS.
Publication Year :: 2020
Publisher :: American Thoracic Society, 2020.

Subjects :: Acetylcysteine
medicine.medical_specialty
Idiopathic pulmonary fibrosis
business.industry
Multicenter trial
Internal medicine
medicine
Combined therapy
Pirfenidone
business
medicine.disease
Gastroenterology
medicine.drug

Database :: OpenAIRE
Journal :: B34. ILD CELLULAR MECHANISMS
Accession number :: edsair.doi...........4323aab4262548430990fab4b91afc75
Full Text :: https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3064

Full Text Access

Tools